These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. CAR T Cells Targeting Podoplanin Reduce Orthotopic Glioblastomas in Mouse Brains. Shiina S; Ohno M; Ohka F; Kuramitsu S; Yamamichi A; Kato A; Motomura K; Tanahashi K; Yamamoto T; Watanabe R; Ito I; Senga T; Hamaguchi M; Wakabayashi T; Kaneko MK; Kato Y; Chandramohan V; Bigner DD; Natsume A Cancer Immunol Res; 2016 Mar; 4(3):259-68. PubMed ID: 26822025 [TBL] [Abstract][Full Text] [Related]
8. CAR T-Cell Therapies in Glioblastoma: A First Look. Migliorini D; Dietrich PY; Stupp R; Linette GP; Posey AD; June CH Clin Cancer Res; 2018 Feb; 24(3):535-540. PubMed ID: 29158268 [TBL] [Abstract][Full Text] [Related]
9. CAR T cells and checkpoint inhibition for the treatment of glioblastoma. Shen SH; Woroniecka K; Barbour AB; Fecci PE; Sanchez-Perez L; Sampson JH Expert Opin Biol Ther; 2020 Jun; 20(6):579-591. PubMed ID: 32027536 [No Abstract] [Full Text] [Related]
10. CAR T-cell therapy for glioblastoma: ready for the next round of clinical testing? Prinzing BL; Gottschalk SM; Krenciute G Expert Rev Anticancer Ther; 2018 May; 18(5):451-461. PubMed ID: 29533108 [TBL] [Abstract][Full Text] [Related]
15. Chimeric antigen receptor-engineered T-cell therapy for liver cancer. Chen Y; E CY; Gong ZW; Liu S; Wang ZX; Yang YS; Zhang XW Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):301-309. PubMed ID: 29861325 [TBL] [Abstract][Full Text] [Related]
16. Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma. Brown CE; Aguilar B; Starr R; Yang X; Chang WC; Weng L; Chang B; Sarkissian A; Brito A; Sanchez JF; Ostberg JR; D'Apuzzo M; Badie B; Barish ME; Forman SJ Mol Ther; 2018 Jan; 26(1):31-44. PubMed ID: 29103912 [TBL] [Abstract][Full Text] [Related]
17. Chimeric antigen receptor T cells: a novel therapy for solid tumors. Yu S; Li A; Liu Q; Li T; Yuan X; Han X; Wu K J Hematol Oncol; 2017 Mar; 10(1):78. PubMed ID: 28356156 [TBL] [Abstract][Full Text] [Related]
18. Development of novel antigen receptors for CAR T-cell therapy directed toward solid malignancies. Chen D; Yang J Transl Res; 2017 Sep; 187():11-21. PubMed ID: 28641074 [TBL] [Abstract][Full Text] [Related]
19. Chimeric antigen receptor-engineered natural killer and natural killer T cells for cancer immunotherapy. Bollino D; Webb TJ Transl Res; 2017 Sep; 187():32-43. PubMed ID: 28651074 [TBL] [Abstract][Full Text] [Related]
20. Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy. Chuntova P; Downey KM; Hegde B; Almeida ND; Okada H Front Immunol; 2018; 9():3062. PubMed ID: 30740109 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]